The European Union's Scientific Committee on Consumer Safety (SCCS) has released a preliminary opinion on the safety of Butylated Hydroxyanisole (BHA), a common antioxidant used in many cosmetic formulations. For UK salon owners and beauty businesses, this development signals a need to be aware of evolving regulatory landscapes, even if direct EU regulation doesn't immediately impact UK operations post-Brexit. Vigilance is key.
Understanding BHA's Role in Products
BHA is primarily valued for its ability to prevent oils within cosmetic products from degrading, thereby extending shelf life and maintaining product integrity. It's a frequent ingredient in oil-rich items like lipsticks, foundations, moisturisers, and hair conditioners. While effective in oil-based formulas, its utility is limited in water-based products. The SCCS opinion focuses on its use in leave-on and rinse-off cosmetic products, and importantly, only for dermal application, excluding oral care and aerosol products where inhalation is a risk.
Safety Concerns and the SCCS Stance
The review stems from concerns regarding BHA's potential as a carcinogen, based on animal studies showing tumour formation at high doses. While direct human extrapolation is complex, the potential for long-term effects is a point of consideration. There are also whispers of endocrine disruption, though the evidence is described as limited. For consumers with sensitive skin, higher concentrations of BHA have also been known to cause irritation or allergic reactions. The SCCS's preliminary view suggests that at concentrations up to 0.07% for direct skin contact, BHA is considered safe. However, this opinion is still open for public comment until January 2026, meaning final conclusions could shift.
Implications for UK Beauty Businesses
While the UK operates under its own regulatory framework, the EU's decisions often serve as a significant influence. Businesses that source ingredients or finished products from the EU, or those that export to the EU, will need to closely monitor the final SCCS opinion. More broadly, this highlights the increasing scrutiny on cosmetic ingredients and the importance of transparency. Salon owners should be prepared for potential shifts in product availability or formulations. If your suppliers are reformulating due to EU pressure, it's wise to understand why and what alternatives are being used. Although BHA is generally used at low levels, for businesses offering bespoke formulations or those in niche markets, knowing the regulatory direction can help future-proof your offerings and ensure you're meeting consumer expectations for safety and efficacy.
